IP Library Granted Patent US 12,361,324
Granted Patent B2
US 12,361,324 · App. 17/976,854 · Granted Jul 15, 2025

Inducing variation in user experience parameters based on sensed rider physiological data in intelligent transportation systems

Inventor: Charles Howard Cella (Pembroke, MA)
Assignee: STRONG FORCE TP PORTFOLIO 2022, LLC
G05D1/0022B60W40/08G01C21/3438G01C21/3461G01C21/3469G01C21/3617G05B13/027G05D1/0088G05D1/0212G05D1/0287G05D1/20G05D1/224G05D1/225G05D1/226G05D1/227G05D1/228G05D1/229G05D1/24G05D1/43G05D1/646G05D1/69G05D1/692G05D1/81G06F40/40G06N3/0418G06N3/045G06N3/08G06N3/086G06N20/00G06Q30/0208G06Q50/188G06Q50/40G06V10/764G06V10/82G06V20/56G06V20/59G06V20/597G06V20/64G07C5/006G07C5/008G07C5/02G07C5/08G07C5/0808G07C5/0816G07C5/0866G07C5/0891G10L15/16G10L25/63B60W2040/0881G05D2101/10G06N3/02G06Q30/0281G06Q50/01
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,361,324
App. No.
17/976,854
Granted
Jul 15, 2025
Kind
B2
Abstract

A system for transportation includes a vehicle interface for gathering physiological sensed data of a rider in the vehicle. The system includes an artificial intelligence-based circuit that is trained on a set of outcomes related to rider in-vehicle experience and that induces, responsive to the sensed rider physiological data, variation in one or more of the user experience parameters to achieve at least one desired outcome in the set of outcomes. The inducing variation includes control of timing and extent of the variation.

Claims (23)

1. A system for transportation, comprising:

a vehicle interface for gathering physiological sensed data of a rider in a vehicle that is indicative of a hormone level of the rider using a physiological sensor, wherein the rider experiences an in-vehicle experience, and wherein the in-vehicle experience includes a set of user experience parameters; and

an artificial intelligence-based circuit that is trained on a set of prior outcomes related to the in-vehicle experience and that induces, responsive to the set of prior outcomes related to the in-vehicle experience, variation in one or more user experience parameters in the set of user experience parameters to promote an optimized hormonal state for the rider that promotes rider safety, wherein the induced variation includes a control of seat positioning in the vehicle, execution of a genetic algorithm, and at least one of: timing or extent of the control of the seat positioning based on the hormone level of the rider, wherein the induced variation includes a variation that is according to a prescribed pattern, wherein the prescribed pattern is prescribed according to a regimen, wherein the regimen is developed to provide at least one of: physical therapy, chiropractic, or other medical health benefits, wherein the other medical health benefits include promoting health of at least one of: joints, muscles, ligaments, or cartilage, and wherein the optimized hormonal state is associated with an optimized hormone level of the rider that is to be detected by the physiological sensor.

2. The system for transportation of claim 1 wherein the physiological sensor is disposed to be worn by the rider, and wherein the physiological sensor is to gather the physiological sensed data that is indicative of the hormone level of the rider.

3. The system for transportation of claim 1 wherein the vehicle interface comprises a vision system disposed to capture and analyze images from a plurality of perspectives of the rider.

4. The system for transportation of claim 1 wherein the set of prior outcomes related to the in-vehicle experience includes at least one of: an outcome that promotes rider safety, an outcome that reduces rider safety, a favorable emotional outcome, an unfavorable emotional outcome, a financial outcome, a performance outcome, a trip duration outcome, an energy utilization outcome, an environmental impact outcome, a traffic avoidance outcome, an entertainment outcome, a fuel efficiency outcome, a rider satisfaction outcome, a health related outcome, or achievement of an objective indicated by the rider interacting with a user interface.

5. The system for transportation of claim 1 wherein the set of prior outcomes related to the in-vehicle experience includes at least one of: an outcome that promotes rider safety, a favorable emotional outcome, achievement of an objective indicated by the rider interacting with a user interface, or avoidance of an outcome that is indicated as undesirable by the rider interacting with the user interface.

6. The system for transportation of claim 1 wherein the physiological sensed data of the rider in the vehicle that is indicative of the detected hormone level of the rider includes a cortisol level of the rider.

7. The system for transportation of claim 1 wherein the physiological sensor is a galvanic skin response sensor.

8. The system for transportation of claim 1 wherein the vehicle is a self-driving vehicle.

9. A method for inducing variation in one or more user experience parameters in a vehicle, comprising:

gathering physiological sensed data of a rider in the vehicle via a physiological sensor of a vehicle interface in the vehicle, wherein the rider experiences an in-vehicle experience, wherein the physiological sensed data is indicative of a detected hormone level of the rider, and wherein the in-vehicle experience includes a set of user experience parameters;

training an artificial intelligence-based circuit, wherein the training is based on a set of outcomes related to the in-vehicle experience; and

inducing, via the artificial intelligence-based circuit, in response to the set of outcomes related to the in-vehicle experience, variation in the one or more user experience parameters in the set of user experience parameters to promote an optimized hormone level for the rider that is detected by the physiological sensor and that promotes rider safety, wherein the inducing variation includes a timing or an extent of control of seat positioning in the vehicle based on a combination of the detected hormone level of the rider and at least one other user experience parameter, wherein the at least one other user experience parameter includes at least one of: temperature, humidity, cabin air source, or audio output in the vehicle, wherein the induced variation includes a variation that is according to a prescribed pattern, wherein the prescribed pattern is prescribed according to a regimen, wherein the regimen is developed to provide at least one of: physical therapy, chiropractic, or other medical health benefits, and wherein the other medical health benefits include promoting health of at least one of: joints, muscles, ligaments, or cartilage, and wherein the inducing variation includes executing a genetic algorithm.

10. The method of claim 9 wherein the variation in the one or more user experience parameters further affects at least one of temperature, humidity, cabin air source, or entertainment system content.

11. The method of claim 9 wherein the vehicle interface comprises at least one wearable sensor disposed to be worn by the rider.

12. The method of claim 9 wherein the vehicle interface comprises a vision system disposed to capture and analyze images from a plurality of perspectives of the rider.

13. The method of claim 9 wherein the variation in the one or more user experience parameters comprises variation in control of the vehicle.

14. The method of claim 9 wherein the set of outcomes related to the in-vehicle experience includes at least one of: an outcome that promotes rider safety, an outcome that reduces rider safety, a favorable emotional outcome, an unfavorable emotional outcome, a financial outcome, a performance outcome, a trip duration outcome, an energy utilization outcome, an environmental impact outcome, a traffic avoidance outcome, an entertainment outcome, a fuel efficiency outcome, a rider satisfaction outcome, a health related outcome, or achievement of an objective indicated by the rider interacting with a user interface.

15. The method of claim 9 wherein the physiological sensed data of the rider in the vehicle that is indicative of the detected hormone level of the rider includes a cortisol level of the rider.

16. The method of claim 9 wherein the physiological sensor is a galvanic skin response sensor.

17. The method of claim 9 wherein the vehicle is at least a semi-autonomous vehicle.

18. The method of claim 17 wherein the vehicle is a self-driving vehicle.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2022
From: CELLA, CHARLES HOWARD
To: STRONG FORCE TP PORTFOLIO 2022, LLC
Reel/Frame 061960/0760 →
Continuity (5)
Continuation 16887557 · May 29, 2020
Continuation 16803220 · Feb 27, 2020
Continuation PCTUS2019053857 · Sep 30, 2019
Provisional Application 62739335 · Sep 30, 2018
Related Publication 20230094450A1 · Mar 30, 2023
References Cited (118)
US 5400734A · Doyon · 1995 [cited by applicant]
US 5566072A · Momose et al. · 1996 [cited by applicant]
US 6058352A · Lu et al. · 2000 [cited by applicant]
US 6188945B1 · Graf et al. · 2001 [cited by applicant]
US 7982620B2 · Prokhorov et al. · 2011 [cited by applicant]
US 8630897B1 · Prada Gomez et al. · 2014 [cited by applicant]
US 8825374B2 · Dimitriadis · 2014 [cited by applicant]
US 8862317B2 · Shin et al. · 2014 [cited by applicant]
US 8996303B1 · Bogovich et al. · 2015 [cited by applicant]
US 9293042B1 · Wasserman · 2016 [cited by applicant]
US 9451396B2 · Takatsuji · 2016 [cited by applicant]
US 9527508B1 · Lee · 2016 [cited by examiner]
US 9649974B1 · Arumugasamy et al. · 2017 [cited by applicant]
US 9744363B2 · Grill, Jr. et al. · 2017 [cited by applicant]
US 9827993B2 · Prokhorov · 2017 [cited by applicant]
US 9889770B2 · Hotary et al. · 2018 [cited by applicant]
US 9914475B2 · Sun et al. · 2018 [cited by applicant]
US 10117109B2 · Madaiah et al. · 2018 [cited by applicant]
US 10122692B2 · MacCarthaigh · 2018 [cited by applicant]
US 10126743B2 · Fukumoto · 2018 [cited by applicant]
US 10147319B1 · Chen · 2018 [cited by examiner]
US 10235859B1 · Hiles · 2019 [cited by examiner]
US 10289618B2 · Fink et al. · 2019 [cited by applicant]
US 10322727B1 · Chan et al. · 2019 [cited by applicant]
US 10322728B1 · Porikli · 2019 [cited by examiner]
US 10346415B1 · Smith et al. · 2019 [cited by applicant]
US 10373522B2 · Byron et al. · 2019 [cited by applicant]
US 10387205B2 · Boutnaru · 2019 [cited by applicant]
US 10387417B1 · Hansen et al. · 2019 [cited by applicant]
US 10387429B2 · Smith-Mickelson et al. · 2019 [cited by applicant]
US 10832261B1 · Chan et al. · 2020 [cited by applicant]
US 10850693B1 · Pertsel et al. · 2020 [cited by applicant]
US 11049383B1 · Shahamad et al. · 2021 [cited by applicant]
US 20050143845A1 · Kaji · 2005 [cited by applicant]
US 20090055824A1 · Rychtyckyj et al. · 2009 [cited by applicant]
US 20090058683A1 · Becker · 2009 [cited by applicant]
US 20090292528A1 · Kameyama · 2009 [cited by applicant]
US 20100134302A1 · Ahn et al. · 2010 [cited by applicant]
US 20100293033A1 · Hall et al. · 2010 [cited by applicant]
US 20110213511A1 · Visconti et al. · 2011 [cited by applicant]
US 20110313259A1 · Hatakeyama · 2011 [cited by examiner]
US 20130070043A1 · Geva · 2013 [cited by examiner]
US 20130188513A1 · Vasseur et al. · 2013 [cited by applicant]
US 20140171752A1 · Park et al. · 2014 [cited by applicant]
US 20140201004A1 · Parundekar et al. · 2014 [cited by applicant]
US 20140218187A1 · Chun et al. · 2014 [cited by applicant]
US 20140257920A1 · Gilman et al. · 2014 [cited by applicant]
US 20140277902A1 · Koch · 2014 [cited by applicant]
US 20140278029A1 · Tonguz et al. · 2014 [cited by applicant]
US 20140278910A1 · Visintainer et al. · 2014 [cited by applicant]
US 20140279021A1 · MacNeille et al. · 2014 [cited by applicant]
US 20150166069A1 · Engelman et al. · 2015 [cited by applicant]
US 20150112800A1 · Binion et al. · 2015 [cited by applicant]
US 20150220991A1 · Butts et al. · 2015 [cited by applicant]
US 20150254955A1 · Fields et al. · 2015 [cited by applicant]
US 20150262239A1 · Goralnick · 2015 [cited by applicant]
US 20150292894A1 · Goddard et al. · 2015 [cited by applicant]
US 20150301602A1 · Dow et al. · 2015 [cited by applicant]
US 20150342007A1 · Anderson et al. · 2015 [cited by applicant]
US 20150344036A1 · Kristinsson et al. · 2015 [cited by applicant]
US 20150379530A1 · Bostick et al. · 2015 [cited by applicant]
US 20160063561A1 · MacNeille et al. · 2016 [cited by applicant]
US 20160104486A1 · Penilla et al. · 2016 [cited by applicant]
US 20160282132A1 · Bostick et al. · 2016 [cited by applicant]
US 20160354027A1 · Benson et al. · 2016 [cited by applicant]
US 20160356617A1 · Verosub et al. · 2016 [cited by applicant]
US 20170026790A1 · Flitsch et al. · 2017 [cited by applicant]
US 20170098231A1 · Dietrich · 2017 [cited by applicant]
US 20170105667A1 · Wei · 2017 [cited by examiner]
US 20170171178A1 · Reynders · 2017 [cited by applicant]
US 20170285642A1 · Rander · 2017 [cited by examiner]
US 20170289184A1 · C et al. · 2017 [cited by applicant]
US 20170299399A1 · Yamaguchi et al. · 2017 [cited by applicant]
US 20170329331A1 · Gao · 2017 [cited by applicant]
US 20170355377A1 · Vijaya Kumar · 2017 [cited by examiner]
US 20170370732A1 · Bender et al. · 2017 [cited by applicant]
US 20180006822A1 · Brickell · 2018 [cited by applicant]
US 20180009444A1 · Grimm et al. · 2018 [cited by applicant]
US 20180032955A1 · Lindawati · 2018 [cited by applicant]
US 20180066833A1 · Draaijer et al. · 2018 [cited by applicant]
US 20180113461A1 · Potnis et al. · 2018 [cited by applicant]
US 20180118218A1 · Miloser · 2018 [cited by applicant]
US 20180143635A1 · Zijderveld et al. · 2018 [cited by applicant]
US 20180174457A1 · Taylor · 2018 [cited by applicant]
US 20180281812A1 · Tochioka et al. · 2018 [cited by applicant]
US 20180297602A1 · Richmond · 2018 [cited by examiner]
US 20190033085A1 · Ogale et al. · 2019 [cited by applicant]
US 20190035394A1 · Tsai · 2019 [cited by applicant]
US 20190049267A1 · Huang · 2019 [cited by examiner]
US 20190049957A1 · Healey · 2019 [cited by examiner]
US 20190049969A1 · Qawami et al. · 2019 [cited by applicant]
US 20190187705A1 · Ganguli et al. · 2019 [cited by applicant]
US 20190193591A1 · Migneco · 2019 [cited by examiner]
US 20190197430A1 · Arditi · 2019 [cited by applicant]
US 20190212967A1 · Stanley et al. · 2019 [cited by applicant]
US 20190222885A1 · Cho et al. · 2019 [cited by applicant]
US 20190225232A1 · Blau · 2019 [cited by examiner]
US 20190232974A1 · Reiley et al. · 2019 [cited by applicant]
US 20190265060A1 · Han et al. · 2019 [cited by applicant]
US 20190357834A1 · Aarts et al. · 2019 [cited by applicant]
US 20190373472A1 · Smith et al. · 2019 [cited by applicant]
US 20190391581A1 · Vardaro · 2019 [cited by examiner]
US 20200023846A1 · Husain et al. · 2020 [cited by applicant]
US 20200070840A1 · Gunaratne · 2020 [cited by examiner]
US 20200074266A1 · Peake et al. · 2020 [cited by applicant]
US 20200097754A1 · Tawari et al. · 2020 [cited by applicant]
US 20200331465A1 · Herman et al. · 2020 [cited by applicant]
US 20210113129A1 · Huang · 2021 [cited by applicant]
US 20210374710A1 · Kuehne · 2021 [cited by applicant]
US 20210390581A1 · Chan et al. · 2021 [cited by applicant]
CN 107364368A · 2017 [cited by applicant]
KR 20150050134A · 2015 [cited by applicant]
WO 2009061687A1 · 2009 [cited by applicant]
WO 2019004468A1 · 2019 [cited by applicant]
Author Unknown, “The Difference Between Robotic Process Automation and Artificial Intelligence”, CFB Bots, retrieved from https://medium.com/@cfb_bots, 7 pages, Apr. 20, 2018. [cited by applicant]
Bojarksi et al., “End to End Learning for Self-Driving Cars”, arXiv preprint arXiv: 1604.07316, Apr. 25, 2016. [cited by applicant]
Popa, Alexandra, et al., “Intelligent Autonomous Driving”, 2018 22nd International Conference on System Theory, Control and Computing (ICSTCC), pp. 53-58, 2018. [cited by applicant]
Kocic et al., “Sim-to-Real Autonomous Vehicle Lane Keeping using Vision”, 2021 29th Telecommunications Forum (TELFOR), pp. 1-8, 2021. [cited by applicant]